Work

Abstract 4368652: Real-World Risk Reduction of Cardiometabolic Comorbidities and Improvement of Biomarkers among Patients with Overweight or Obesity Treated with Semaglutide 2.4 mg

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4368652

Authors: Aleksandrina Ruseva, Matthew Bassan, Ella Du, Anthony Fabricatore, Briain O Hartaigh, Wojciech Michalak, Ramya Ramasubramanian, Pangsibo Shen, Jinlin Song, Zhenxiang Zhao, Francisco Lopez-Jimenez

Institutions: Analysis Group (United States), Mayo Clinic

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415799774

Cites:

Cited by:

Related to: